Erasca (ERAS) Total Liabilities (2020 - 2026)
Erasca (ERAS) posted Total Liabilities of $67.7 million for Q1 2026, down 4.62% on a QoQ basis from $71.0 million in Q4 2025, and down 5.63% year-over-year from $71.7 million in Q1 2025.
Erasca (ERAS) Total Liabilities (2020 - 2026) Analysis & Trends
Erasca's Total Liabilities history runs 7 years deep, the most recent figure standing at $67.7 million for Q1 2026.
- Quarterly Total Liabilities fell 5.63% year-over-year to $67.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $67.7 million (down 5.63% YoY) and the FY2025 annual result came in at $71.0 million, down 10.18% from the prior year.
- Total Liabilities was $67.7 million for Q1 2026 at Erasca, down from $71.0 million in the prior quarter.
- Across five years, Total Liabilities topped out at $103.1 million in Q4 2022 and bottomed at $49.8 million in Q2 2022.
- A 5-year average of $74.9 million and a median of $78.0 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities jumped 154.09% — and 2023, when it retreated 23.72%.
- Erasca's Total Liabilities stood at $103.1 million in 2022, then slipped by 23.72% to $78.6 million in 2023, then gained by 0.53% to $79.0 million in 2024, then declined by 10.18% to $71.0 million in 2025, then decreased by 4.62% to $67.7 million in 2026.
- Business Quant data shows ERAS's Total Liabilities at $67.7 million in Q1 2026, $71.0 million in Q4 2025, and $72.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Erasca | 5.89 Bn | 5.89 Bn | - | 67.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.71 Mn |
| Dec 31, 2025 | 70.98 Mn |
| Sep 30, 2025 | 72.52 Mn |
| Jun 30, 2025 | 73.13 Mn |
| Mar 31, 2025 | 71.74 Mn |
| Dec 31, 2024 | 79.03 Mn |
| Sep 30, 2024 | 78.85 Mn |
| Jun 30, 2024 | 74.66 Mn |
| Mar 31, 2024 | 81.61 Mn |
| Dec 31, 2023 | 78.61 Mn |
| Sep 30, 2023 | 80.43 Mn |
| Jun 30, 2023 | 77.96 Mn |
| Mar 31, 2023 | 81.09 Mn |
| Dec 31, 2022 | 103.06 Mn |
| Sep 30, 2022 | 81.11 Mn |
| Jun 30, 2022 | 49.76 Mn |
| Mar 31, 2022 | 50.81 Mn |
| Dec 31, 2021 | 44.89 Mn |
| Sep 30, 2021 | 38.96 Mn |
| Jun 30, 2021 | 19.58 Mn |